Monthly Archives: October 2010

Hitting ’em where it hurts: BPA reduces sperm quantity and quality in male workers

Richard Denison, Ph.D., is a Senior Scientist.

As reported by Rob Stein in the Washington Post this morning, a NIOSH-funded study of male Chinese workers conducted by researchers at Kaiser-Permanente in Oakland, California has found that exposure to the endocrine-disrupting chemical bisphenol A (BPA) significantly increases the incidence of low sperm counts and concentrations, as well as lowered sperm motility and higher mortality.

The 5-year study, published in the peer-reviewed journal Fertility and Sterility (that’s a title only slightly more cheery than the CDC’s publication Morbidity and Mortality!), shows that the same kinds of adverse effects of BPA on sperm already observed in animal studies also occur in humans with detectable levels of BPA in their urine.

And while the most pronounced effects were observed in highly exposed workers, the authors of the study note:

Similar dose-response associations were observed among participants with only environmental BPA exposure at levels comparable to men in the general United States population.

Despite a markedly reduced sample size in this group of men exposed only to low environmental BPA sources, the inverse correlation between increased urine BPA level and decreased sperm concentration and total sperm count remain statistically significant.

Read More »

Posted in Emerging science, Health science / Tagged , , , , , , | Read 2 Responses

Public health advocates to the chemical industry: Stop hobbling EPA

Richard Denison, Ph.D., is a Senior Scientist.  Allison Tracy is a Chemicals Policy Fellow.

Today, EDF joined with 32 other environmental justice, health and environmental organizations to file comments [PDF] with EPA that strongly support its effort to improve its ability to obtain – and share with the public – robust information about the production, processing and use of chemicals in the U.S.

While the details of EPA’s proposed rule and many of our comments are heavily wonky, the motivation and goals are far from it:  To make sure that EPA, the marketplace and the public have the information they need to guard against harm from dangerous chemicals.  That requires knowing a whole lot more than we do today about what chemicals are in commerce, in what quantities, how they’re used – essential to understanding how we may be exposed.

Robust information is the lifeblood of a sound chemicals management system.  Government needs access to comprehensive, reliable information to inform policy, programmatic and regulatory decisions it must make to carry out its mission.  The market needs access to such information to inform the myriad decisions made every day by producers, sellers and users of chemicals and products and materials made using chemicals.  And researchers, the public and groups that work in the public interest need access if they are to have confidence in, and be able meaningfully to contribute to, decisions and actions taken by government and the private sector.

In an earlier post, we made the point that the chemical industry’s reactions to these modest proposals will be a litmus test for how serious it is in acting on its rhetoric about the need for EPA and the public to have more and better information on chemicals.  With the comment period closing today for EPA’s proposed rule, look here in the coming weeks for our assessment on industry’s comments.

What follows is a summary of our comments, indicating both what we support and what more is needed.  Read More »

Posted in Health policy, Industry influence, Regulation / Tagged , , , | Comments are closed